Book Building - SME
₹ - cr
₹ 0
-
₹ -
NSE - SME
-
-
-
Initial public offer of upto 48,10,000 equity shares of face value of Rs. 10/- each (Equity Shares) of the company at an issue price of Rs. [*] per equity share (including a share premium of Rs. [*] per equity share) for cash, aggregating up to Rs. [*] crores (Public Issue) out of which [*] equity shares of face value of Rs. 10/- each, at an issue price of Rs. [*] per equity share for cash, aggregating Rs. [*] crores will be reserved for subscription by the market maker to the issue (the Market Maker Reservation Portion). The public issue less market maker reservation portion i.e. issue of [*] equity shares of face value of Rs. 10/- each, at an issue price of Rs. [*] per equity share for cash, aggregating up to Rs. [*] crores is hereinafter referred to as the Net Issue. The public issue and net issue will constitute [*] % and [*] % respectively of the post-issue paid-up equity share capital of the company. The price band and the minimum bid lot will be decided by the company.
Upgradation of existing mfg unit 1 to mfg large volume parentals for intravenous use. Setting up a high-speed cartooning packaging line at existing mfg unit 2 for Dry Powder Injections. Prepayment or repayment of all or a portion of certain loans availed by the company. General corporate purposes.
Onyx Biotec Ltd, T-34 2nd Floor, Okhla Industrial Are, Phase II, New Delhi - 110020
Phone - 91-011-26387281/83
Fax -
Email - generalinfo@onyxbiotec.com
Website - www.onyxbiotec.com